AU Stock MarketDetailed Quotes

ILA Island Pharmaceuticals Ltd

Watchlist

0.185
-0.010-5.13%

20min DelayNot Open Dec 2 10:42 AET

28.87MMarket Cap-5781P/E (Static)

Island Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

Total revenue

11,211.12%1.25M

11.07K

Operating revenue

11,211.12%1.25M

--11.07K

----

Cost of revenue

Gross profit

11,211.12%1.25M

11.07K

Operating expense

41.86%4.13M

3.53%2.91M

31.33%2.81M

2.14M

Selling and administrative expenses

-10.23%1.44M

0.34%1.6M

-15.90%1.6M

--1.9M

-General and administrative expense

-10.23%1.44M

0.34%1.6M

-15.90%1.6M

--1.9M

Research and development costs

99.24%2.27M

10.77%1.14M

39,690.42%1.03M

--2.59K

Other operating expenses

153.22%412.18K

-9.57%162.77K

-23.30%180K

--234.7K

Operating profit

0.80%-2.87M

-3.13%-2.9M

-31.33%-2.81M

-2.14M

Net non-operating interest income (expenses)

-360.97%-41.49K

-9K

Non-operating interest income

--4.71K

----

Non-operating interest expense

413.34%46.2K

--9K

----

Other net income (expenses)

-32.62%50.95K

-62.59%75.62K

1,558.34%202.12K

12.19K

Other non-operating income (expenses)

-32.62%50.95K

-62.59%75.62K

1,558.34%202.12K

--12.19K

Income before tax

-1.20%-2.86M

-8.58%-2.83M

-22.58%-2.61M

-2.13M

Income tax

Earnings from equity interest net of tax

Net income

-1.20%-2.86M

-8.58%-2.83M

-22.58%-2.61M

-2.13M

Net income continuous operations

-1.20%-2.86M

-8.58%-2.83M

-22.58%-2.61M

---2.13M

Noncontrolling interests

Net income attributable to the company

-1.20%-2.86M

-8.58%-2.83M

-22.58%-2.61M

-2.13M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-1.20%-2.86M

-8.58%-2.83M

-22.58%-2.61M

-2.13M

Diluted earnings per share

1.90%-0.0317

-8.07%-0.0323

71.78%-0.0299

-0.106

Basic earnings per share

1.90%-0.0317

-8.07%-0.0323

71.78%-0.0299

-0.106

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021
Total revenue	11,211.12%1.25M	11.07K
Operating revenue	11,211.12%1.25M	--11.07K	----	----
Cost of revenue
Gross profit	11,211.12%1.25M	11.07K
Operating expense	41.86%4.13M	3.53%2.91M	31.33%2.81M	2.14M
Selling and administrative expenses	-10.23%1.44M	0.34%1.6M	-15.90%1.6M	--1.9M
-General and administrative expense	-10.23%1.44M	0.34%1.6M	-15.90%1.6M	--1.9M
Research and development costs	99.24%2.27M	10.77%1.14M	39,690.42%1.03M	--2.59K
Other operating expenses	153.22%412.18K	-9.57%162.77K	-23.30%180K	--234.7K
Operating profit	0.80%-2.87M	-3.13%-2.9M	-31.33%-2.81M	-2.14M
Net non-operating interest income (expenses)	-360.97%-41.49K	-9K
Non-operating interest income	--4.71K	----	----	----
Non-operating interest expense	413.34%46.2K	--9K	----	----
Other net income (expenses)	-32.62%50.95K	-62.59%75.62K	1,558.34%202.12K	12.19K
Other non-operating income (expenses)	-32.62%50.95K	-62.59%75.62K	1,558.34%202.12K	--12.19K
Income before tax	-1.20%-2.86M	-8.58%-2.83M	-22.58%-2.61M	-2.13M
Income tax	0	0	0	0
Earnings from equity interest net of tax
Net income	-1.20%-2.86M	-8.58%-2.83M	-22.58%-2.61M	-2.13M
Net income continuous operations	-1.20%-2.86M	-8.58%-2.83M	-22.58%-2.61M	---2.13M
Noncontrolling interests
Net income attributable to the company	-1.20%-2.86M	-8.58%-2.83M	-22.58%-2.61M	-2.13M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-1.20%-2.86M	-8.58%-2.83M	-22.58%-2.61M	-2.13M
Diluted earnings per share	1.90%-0.0317	-8.07%-0.0323	71.78%-0.0299	-0.106
Basic earnings per share	1.90%-0.0317	-8.07%-0.0323	71.78%-0.0299	-0.106
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data